Abstract:Objective To investigate the regulatory role and its mechanism of transforming growth factor-β (TGF-β)/Smad pathway on the balance of helper T cell 17/T-regulatory cells (Th17/Treg) in a mouse model of acute lung injury (ALI). Methods Sixty C57BL/6 mice were divided into three groups according to randomize number table method: control group (n = 20), ALI model group (n = 20), and interleukin-17 (IL-17) antibody (Ab) pretreatment group (n = 20). The mice in IL-17 Ab pretreatment group were delivered 200 μg IL-17 Ab intraperitoneally, while the ALI model group were given 200 μg Iso-IgG2a. Both groups were challenged by 4 mg/kg lipopolysaccharides (LPS) [dissolved in 30 μL phosphate buffer saline (PBS)] intratracheally to induce ALI. The mice in control group were given 30 μL PBS. Twenty-four hours later, all mice were sacrificed and lung tissues and bronchoalveolar lavage fluid (BALF) were harvested. The pathological images were observed under light microscope, the lung wet weight/dry weight (W/D) ratio and the protein content in BALF were measured to assess the severity of lung injury. The levels of IL-6, IL-10, IL-17A and TGF-β1 in lung homogenates were assessed by enzyme-linked immunosorbent assay (ELISA). The ratio of Treg and Th17 was examined by flow cytometer. The mRNA expression levels of retinoid-related orphan nuclear receptor γt (ROR-γt), TGF-β1, Foxp3, Smad2, Smad3 and Smad7 were quantitatively measured by real-time polymerase chain reaction (PCR). The phosphates Smad2/3 and Smad7 (p-Smad2/3, p-Smad7) of lung tissues were detected by Western Blot. Results Compared with the control group, a large number of inflammatory cells infiltration could be observed and accompanied by alveolar septal thickening, alveolar congestion and edema/collapse and dot bleeding; the ratio of W/D, the protein levels in BALF, the concentrations of IL-6, IL-17A and TGF-β1 in lung tissue homogenates, the ratio of Th17/Treg and the mRNA expressions of ROR-γt, TGF-β1, Foxp3, Smad2, and Smad3 were significantly elevated, the mRNA expression of Smad7 was significantly decreased in the ALI model group (all P < 0.05). Interestingly, compared with the ALI model group, the obvious reduction in the disruption of lung tissue structure and congestion were seen under light microscope; the ratio of W/D (5.84±0.65 vs. 8.27±1.32), the protein levels in BALF (g/L: 0.09±0.02 vs. 0.18±0.05), the concentrations of IL-6 (pg/mg: 465±105 vs. 1 098±145), IL-17A (pg/mg: 32±12 vs. 876±178) and TGF-β1 (pg/mg: 45±10 vs. 96±26) in lung tissue homogenates were significantly decreased in IL-17 Ab pretreatment group (all P < 0.05). In addition, all mice with pretreatment of IL-17 Ab resulted in significantly reduced percentage of Th17 [(6.78±0.35)% vs. (11.32±1.25)%] and ratio of Th17/Treg (1.24±0.29 vs. 1.98±0.21), mRNA expressions of ROR-γt, TGF-β1, Smad2, and Smad 3 (2-ΔΔCt: 1.04±0.05 vs. 2.32±0.34, 2.38±0.12 vs. 3.48±0.31, 2.44±0.12 vs. 3.25±0.34, 2.36±0.09 vs. 2.98±0.13), and the p-Smad2/3 (A value: 1.78±0.25 vs. 2.58±0.32) was significantly decreased, while the mRNA (2-ΔΔCt: 0.84±0.09 vs. 0.69±0.03) and protein expression of p-Smad7 (A value: 0.76±0.12 vs. 0.53±0.05) was significantly up-regulated in lung tissue homogenates, the differences were statistically significant (all P < 0.05). The mRNA expression of Foxp3 (2-ΔΔCt: 1.74±0.05 vs. 1.62±0.13, P > 0.05) was similar. There were no significant differences in protein levels of IL-10 of lung tissue among all the groups. Conclusion The imbalance of Th17/Treg may play an important role in the immunological mechanism of ALI, which may be partially modulated by TGF-β/Smad pathway.

IL-33 Deficiency Attenuates Lung Inflammation by Inducing Th17 Response and Impacting the Th17/Treg Balance in LPS-Induced ARDS Mice via Dendritic Cells

The Role of IL-33 on LPS-Induced Acute Lung Injury in Mice

[Knockdown of IL-33 suppresses the expression of inflammatory factors and NLRP3 to inhibit the inflammatory response in asthmatic mice]

Effect of Interleukin-33 on Th1/Th2 Cytokine Ratio in Peripheral Lymphocytes in Asthmatic Mice.

IL-33 amplifies airways inflammation in a murine surrogate of asthma possibly through acting on dendritic cells

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

IL-33 induced inflammation exacerbated the development of chronic obstructive pulmonary disease through oxidative stress

IL-33/ST2 axis deficiency exacerbates neutrophil-dominant allergic airway inflammation

IL-33 Protects Mice Against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses As Well As Decreasing Th17 Cell Response

Elevated IL-33 Promotes Expression of MMP2 and MMP9 Via Activating STAT3 in Alveolar Macrophages During LPS-induced Acute Lung Injury.

Interleukin-33 is Released in Spinal Cord and Suppresses Experimental Autoimmune Encephalomyelitis in Mice.

Interleukin-37 Attenuates Lipopolysaccharide (LPS)-Induced Neonatal Acute Respiratory Distress Syndrome in Young Mice via Inhibition of Inflammation and Cell Apoptosis

Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice

Role of IL-17 in LPS-induced Acute Lung Injury: an in Vivo Study

[Changes and Role Evaluation of TNF-α and IL-1β in Lung Tissues of ARDS Mice].

Blockade of Interleukin‐17 Restrains the Development of Acute Lung Injury

Interleukin-34 induces pulmonary inflammation in a murine model of lipopolysaccharide-induced acute lung injury

Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice

IL-33-activated dendritic cells are critical for allergic airway inflammation.

Regulatory role of transforming growth factor-β/Smad pathway on immune imbalance in a mouse model of acute lung injury

IL-33 Promotes ST2-dependent Lung Fibrosis by the Induction of Alternatively Activated Macrophages and Innate Lymphoid Cells in Mice